TEKT3

Across TCGA pan-cancer cohorts, TEKT3 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated TEKT3 data layer compared with 28 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher TEKT3 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated TEKT3 expression acts as an unfavorable survival marker.

LUAD, UCEC, and LSCC are the cancer types where TEKT3 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	III,IV	0.757	1.000	.022	5	view →
UCEC	OS	Median	All	0.787	1.000	.043	2	view →
LSCC	OS	Median	All	0.943	1.000	.049	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

TEKT3–LUAD (OS)

Open the LUAD breakdown →